Related Experiment Videos
Minimally invasive trabecular meshwork surgery for open-angle glaucoma
Kalyan Vemulapalli1, Rishikesh Gandhewar2, Tsz Wing Yim3
1Department of Ophthalmology, Royal Berkshire NHS Trust, Reading, UK.
The Cochrane Database of Systematic Reviews
|July 21, 2026
Summary
Minimally invasive Schlemm's canal surgery (SC-MIGS) shows uncertain benefits for glaucoma patients. While it may increase medication-free status short-term compared to phacoemulsification alone, it carries a higher bleeding risk and offers limited advantages over other MIGS or non-MIGS surgeries.
Area of Science:
- Ophthalmology
- Glaucoma Surgery
- Intraocular Pressure Management
Background:
- Glaucoma is a leading cause of irreversible blindness, necessitating effective intraocular pressure (IOP) management.
- Minimally invasive glaucoma surgery (MIGS) techniques, specifically those targeting Schlemm's canal (SC-MIGS), aim to optimize IOP control and slow glaucoma progression.
- This review updates and expands upon previous research on SC-MIGS for open-angle glaucoma.
Purpose of the Study:
- To evaluate the efficacy and safety of SC-MIGS compared to medical, laser, or other surgical treatments for open-angle glaucoma.
- To assess outcomes including medication-free status, IOP reduction, visual field progression, and adverse events.
Main Methods:
- A systematic review of randomized controlled trials (RCTs) was conducted, searching multiple databases up to October 2025.
- Included RCTs compared SC-MIGS procedures (e.g., goniotomy, canaloplasty) against non-MIGS, other MIGS, laser, or medical therapy.
- Data synthesis involved meta-analysis where possible, or narrative summaries for heterogeneous data, using Cochrane methodology.
Main Results:
- Evidence for SC-MIGS versus non-MIGS surgery showed no significant short-term differences in medication-free status or IOP.
- SC-MIGS combined with phacoemulsification may increase short-term medication-free participants but also increases bleeding risk compared to phacoemulsification alone.
- Comparisons between SC-MIGS and other SC-MIGS or laser treatments yielded limited evidence of significant differences, though SC-MIGS may offer greater IOP reduction versus laser.
Conclusions:
- The current evidence for SC-MIGS is of low to very low certainty, leading to weak conclusions.
- SC-MIGS shows potential for increased medication-free status short-term when combined with phacoemulsification, but with an elevated risk of bleeding.
- SC-MIGS may provide a greater IOP reduction compared to laser treatment, but overall benefits and risks require further investigation.
Related Concept Videos
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...